Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
PAREXEL INTERNATL Add to My Watchlist (NSDQ: PRXL) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Parexel 19.25 -0.48 (-2.43%) 750,609
200 West Street
Waltham, MA 02451 US
(781) 487-9900
(781) 487-0525 fax
www.parexel.com
CEO Josef H. von Rickenbach
Auditor Ernst & Young LLP
Exchange Traded NQ
ISIN Number US6994621075
CIK Number 799729
NAICS Code 541711
Business Summary
A biopharmaceutical company, providing expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the pharmaceutical, biotechnology, and medical device industries.
Number of Employees 9,275
Share Fundamentals
Market Cap 1.12B
Shares Outstanding 58.09M
Float 49.08M
Short Interest 2.05M
Financial Strength
Revenue (TTM) $1,248,846,000
Earnings (TTM) $36,371,000
Quick Ratio 1.3:1
Current Ratio 1.5:1
Total Debt/Equity 0.63:1
Profitability
Gross Margin 30.5%
EBITDA Margin 10.3%
Profit Margin 4.9%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs